Bio Rad Laboratories Stock Analysis

Bio Stock Analysis Notes

About 16.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.21. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bio Rad Laboratories has Price/Earnings To Growth (PEG) ratio of 1.19. The entity recorded a loss per share of 24.0. The firm had not issued any dividends in recent years. Bio Rad had 2:1 split on the 8th of March 2002. Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. Bio-Rad Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 8200 people. For more info on Bio Rad Laboratories please contact Norman Schwartz at 510 724 7000 or go to https://www.bio-rad.com.

Bio Rad Laboratories Investment Alerts

Bio Largest EPS Surprises

View All Earnings Estimates

Bio Rad Environmental, Social, and Governance (ESG) Scores

Bio Stock Institutional Investors

Note, although Bio Rad's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bio Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 8.13 B.

Bio Profitablity

The company has Net Profit Margin of (0.26) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.1 %, which entails that for every 100 dollars of revenue, it generated $0.1 of operating income.

Management Efficiency

Bio Rad Laboratories has Return on Asset of 0.0157 % which means that on every $100 spent on assets, it made $0.0157 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.095) %, meaning that it generated no profit with money invested by stockholders. Bio Rad's management efficiency ratios could be used to measure how well Bio Rad manages its routine affairs as well as how well it operates its assets and liabilities. As of the 9th of February 2026, Return On Tangible Assets is likely to grow to -0.23. In addition to that, Return On Capital Employed is likely to drop to 0.03. At this time, Bio Rad's Debt To Assets are very stable compared to the past year. As of the 9th of February 2026, Fixed Asset Turnover is likely to grow to 5.50, while Non Currrent Assets Other are likely to drop about 65 M.

Technical Drivers

As of the 9th of February, Bio Rad shows the Risk Adjusted Performance of (0.01), mean deviation of 1.22, and Standard Deviation of 1.69. Bio Rad Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Bio Rad Laboratories Price Movement Analysis

Bio Rad Laboratories Insider Trading Activities

Bio Rad Outstanding Bonds

Bio Rad Predictive Daily Indicators

Bio Rad Corporate Filings

Bio Rad Forecast Models

Bio Rad's time-series forecasting models are one of many Bio Rad's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bio Rad's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Bio Rad Bond Ratings

Bio Rad Laboratories financial ratings play a critical role in determining how much Bio Rad have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Bio Rad's borrowing costs.

Bio Rad Laboratories Debt to Cash Allocation

Bio Rad Laboratories has 1.37 B in debt with debt to equity (D/E) ratio of 0.16, which may show that the company is not taking advantage of profits from borrowing. Bio Rad Laboratories has a current ratio of 5.39, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. That said, strategic use of leverage may enable Bio to fund expansion initiatives and generate superior returns.

Bio Rad Total Assets Over Time

Bio Rad Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Bio Rad uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Bio Rad Debt Ratio

24.0

It appears that most of the Bio Rad's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Bio Rad's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Bio Rad, which in turn will lower the firm's financial flexibility.

Bio Rad Corporate Bonds Issued

Bio Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bio Rad prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bio Rad. By using and applying Bio Stock analysis, traders can create a robust methodology for identifying Bio entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bio analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bio analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Bio Rad Laboratories stock analysis indicators help investors evaluate how Bio Rad stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bio Rad shares will generate the highest return on investment. By understating and applying Bio Rad stock analysis, traders can identify Bio Rad position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Bio Rad Laboratories's market price often diverges from its book value, the accounting figure shown on Bio's balance sheet. Smart investors calculate Bio Rad's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Bio Rad's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.

It's important to distinguish between Bio Rad's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bio Rad should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.